We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gresham Technologies Plc | LSE:GHT | London | Ordinary Share | GB0008808825 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 163.00 | 162.00 | 164.00 | 163.00 | 163.00 | 163.00 | 25,329 | 07:33:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Computer Programming Service | 48.72M | 2.88M | 0.0344 | 47.38 | 136.63M |
Date | Subject | Author | Discuss |
---|---|---|---|
27/10/2020 08:23 | They are better than what you would like. Abbreviated Mental Test (AMT) Please do your own research as always | qantas | |
27/10/2020 08:12 | Perhaps you could comment on the numbers, sorry Qantas not Quantas | amt | |
27/10/2020 08:09 | Quantas why paste what we all can read? | amt | |
27/10/2020 07:59 | The Clareti ARR of 11.9 was already announced in the recent acquistion | zipstuck | |
27/10/2020 07:24 | The trading update seems incomprehensible to me, anything but clarity. On first reading nearly all Clarity revenue seems to be from ANZ or 50% of total anyway. Why can't they just present a table with numbers showing predicted sales, order book and forcast for 2021 showing clarity (excuse the pun) and total. On the other hand this could be read as an excellent update with already 40% more clarity contracted for in 2021 so maybe it could increase much more. Can anyone help? | amt | |
22/10/2020 10:13 | Htps://www.thetraden Jade tic 13 this is about Euronext technical glitch sees major cash and derivatives market close failure PLease do your own research as always. | qantas | |
21/10/2020 15:01 | Jade tic 13 this is about Demystifying the CAT: Why Compliance is More Than a Tick Box Exercise. Please do your own research as always. | qantas | |
20/10/2020 15:43 | Jade tic 13 Think you may be a grand tic don't know why you are checking all my posts and I don't have to explain myself to you. Get a life it is banking related. Please do your own research as always. | qantas | |
20/10/2020 10:55 | Qantas, have you posted this on the wrong thread? If not what is the relevance of it to us? | jadeticl3 | |
20/10/2020 09:47 | UBS Profits up 99% Please do your own research as always. | qantas | |
13/10/2020 21:07 | Please do your own research as always | qantas | |
12/10/2020 21:39 | Please do your own research as always | qantas | |
12/10/2020 11:25 | Gresham Technologies PLC Board Changes 12/10/2020 7:00am UK Regulatory (RNS & others) Gresham Technologies (LSE:GHT) Intraday Stock Chart Monday 12 October 2020 Click Here for more Gresham Technologies Charts. TIDMGHT RNS Number : 6893B Gresham Technologies PLC 12 October 2020 RNS 12 October 2020 Gresham Technologies plc Wealth of banking and fintech experience to join Board Gresham Technologies plc (LSE: "GHT", "Gresham" or the "Company"), the leading software and services company that specialises in providing solutions for data integrity and control, banking integration, payments and cash management, announces the appointments of Jenny Knott and Dr. Ruth Wandhöfer as Non-Executive Directors effective from 12 October 2020. These appointments bring a wealth of banking and financial technology experience to the Board in parallel with the recent successful completion of the Chair succession. Jenny Knott is a qualified accountant and has held roles as Chief Executive, Chief Finance Officer and Chief Operational Officer in banking and in financial technology. She built a reputation as an advocate of technology-enabled modernisation in the financial services sector throughout her executive career, which includes roles at Standard Bank, Nomura Securities and UBS. Whilst CEO of NEX Optimisation, the post-trade, risk and information services business, she was named as one of the top 100 influencers by Financial Technologist in 2018. She is currently Chair of Equiida, the board effectiveness and leadership consultancy, and Non-Executive Director of SimplyHealth. Dr. Ruth Wandhöfer is a Global Fintech 50 Influencer with considerable experience in the Fintech and RegTech sectors. Her executive career included over a decade at Citi in the transaction services business, including Global Head of Regulatory & Market Strategy for Treasury and Trade Solutions. Prior to this she spent four years as a Policy Adviser on Securities Services and Payments at the European Banking Federation. Following her executive career, she served as Non-Executive Director of the London Stock Exchange and is currently Partner at Gauss Ventures and independent Non-Executive Director at Permanent TSB and Digital Identity Net. Imogen Joss will continue in her role as Non-Executive Director, Senior Independent Director and Chair of the Remuneration Committee until 31 October 2020 when she will step down from the Board. Jenny Knott will assume responsibility as Chair of the Remuneration Committee and Andy Balchin, currently Non-Executive Director and Chair of the Audit Committee, will assume the role of Senior Independent Non-Executive Director. Peter Simmonds, Chairman, commented: "We are delighted to have Jenny and Ruth join the Board. They bring deep experience in global banking and financial technology to the Company at an exciting time as we look to accelerate the Clareti business and further monetise the wealth of IP that the Company has developed and acquired in recent years. I would like to thank Imogen Joss for her contribution to the Company over the last four years. I would also like to thank my predecessor, Ken Archer, who so ably chaired the business over the last decade and who formally stepped down from the Board at the end of September." Jennifer Catherine Knott, aged 52, does not hold any current directorships in publicly quoted companies. Additionally, she has not held any directorships in publicly quoted companies in the last five years. She has no beneficial interest in the Company as at today's date. Ruth Wandhöfer, aged 44, is currently director of Permanent TSB Group Holdings plc. and in the last five years, she has been a director of London Stock Exchange Group plc. Her total beneficial interest in the Company is 13,403 Ordinary Shares, representing 0.02% of the Company's total issued share capital as at today's date. The Company confirms that there are no additional matters requiring disclosure under rule 9.6.13 of the Listing Rules in relation to the appointments of either of the directors. Enquiries Please do your own research as always. | qantas | |
10/10/2020 21:46 | Please do your own research as always | qantas | |
09/10/2020 17:14 | Well said jade tic 13 This is my private thread chat line. Please do your own research as always. | qantas | |
09/10/2020 10:19 | Everyone fell asleep watching paint dry. Perhaps a discussion on chances of trade having picked up would help. No news, so no change from the view that year end expectations are likely to be met although we are now in the most important trading months. I suppose if there are no more updates before the end of October we can go back to sleep. I don't think there any expected regular trading updates are there? I generally think everyone underestimates the pain in switching over to a SAAS model, the revenue drop spans multiple years. | planit2 | |
09/10/2020 09:53 | Has everyone except QANTAS left this site? | jadeticl3 | |
09/10/2020 09:37 | Please do your own research as always. | qantas | |
07/10/2020 16:39 | Please do your own research as always. | qantas | |
06/10/2020 17:11 | Please do your own research as always. | qantas | |
06/10/2020 12:49 | Please do your own research as always. | qantas | |
05/10/2020 13:39 | Please do your own research as always.. | qantas |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions